Table 10Lifetime modelled events for a cohort of 1,000 ACS patients treated with either low or high intensity statins

Heath stateLow IntensityHigh Intensity
MI386400
 Stroke112102
 Heart Failure317246
 Revascularisations444431
 Unstable Angina270258
 Cardiovascular Mortality389333
 Death from other causes611666

From: Appendix C, Health Economic Modelling

Cover of Lipid Modification
Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease [Internet].
NICE Clinical Guidelines, No. 67.
National Collaborating Centre for Primary Care (UK).
Copyright © 2008, Royal College of General Practitioners.

All rights reserved. No part of this publication may be reproduced in any form (including photocopying or storing it in any medium by electronic means and whether or not transiently or incidentally to some other use of this publication) without the written permission of the copyright owner. Applications for the copyright owner’s written permission to reproduce anypart of this publication should be addressed to the publisher.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.